MedTrace Logo

Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders

NCT04680130 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-11-21

No results posted yet for this study

Summary

The investigators aim to learn more about symptoms suggestive of a neurodegenerative process.

Conditions

  • PSP
  • CBD
  • PCA
  • LPA
  • Semantic Dementia
  • Semantic Aphasia
  • Behavioral Variant of Frontotemporal Dementia
  • FTD
  • PPA
  • Apraxia of Speech
  • MSA - Multiple System Atrophy
  • Parkinson Disease

Interventions

DRUG

C-11 PiB

Completing PET scan looking for amyloid protein

DRUG

AV1451 Tau

Completing PET scan looking for tau protein

DRUG

C-11 ER176

Completing PET scan looking for neuroinflammation

Sponsors & Collaborators

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2050-11-30
Completion
2050-11-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04680130 on ClinicalTrials.gov